U.K. Imaging Services Market Growth & Trends
The U.K. imaging services market size is expected to reach USD 23.84 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.9% from 2022 to 2030. Medical imaging technologies are highly useful in detecting changes in the appearance of organs, tissues, and arteries, as well as diagnosing various diseases like cancer. Each modality has its own set of advantages for effectively identifying a variety of medical conditions. The prevalence of various disorders is predicted to increase market growth.
Emerging innovations in medical imaging technology and their adoption by service providers are expanding the market size.
For instance, in May 2020, Alliance Medical and Expandable Healthcare announced the launch of Mobile Medical Plus in the U.K., a mobile imaging unit with an in-patient facility. Furthermore, the market is likely to grow over the forecast period due to the increased prevalence of chronic diseases such as cancer and cardiovascular disorders, which necessitates the use of advanced medical imaging technologies for diagnosis. As per the International Agency for Research on Cancer, about 457,960 new cancer cases were diagnosed in the U.K. in 2020, with 179,648 fatalities in the same year.
With the adoption of modern imaging technology, the number of imaging service providers in the U.K. is rapidly increasing. According to the Organization for Economic Co-operation and Development (OECD), hospitals had around 7.8 MRI units and 9 CT units installed per 1,000,000 population in 2020. Furthermore, the rising frequency of CT scans in the U.K. is predicted to boost the overall market growth. According to the same source, CT scans were performed in U.K. hospitals at a rate of 103 per 1,000 people in 2019. The low cost of CT scans compared to MRI scans is also expected to increase their uptake.
In order to grow their services and presence, the market's leading competitors are undertaking various efforts such as acquisitions and funding of medium and small-sized organizations. For instance, in March 2021, Fortius Clinic, U.K.'s single largest orthopedic group with an international reputation in orthopedics and MSK, was acquired by Affidea Group, the leading European provider of diagnostic imaging, outpatient, and cancer care services. In July 2020, Rutherford Health entered into a partnership with Somerset NHS Foundation Trust, to provide diagnostic services through a new diagnostics facility in Somerset, England. The diagnostics facility is expected to offer a variety of diagnostic services and assist in the delivery of test results.
Enquire for customization in Report @https://www.grandviewresearch.com/checkout/select-license/uk-imaging-services-market-report
U.K. Imaging Services Market Segmentation
Grand View Research has segmented the U.K. imaging services market based on modality and end-use:
Modality Outlook (Revenue, USD Billion, 2018 – 2030)
- CT Scans
- MRI Scans
- Nuclear Medicine Scans
End-use Outlook (Revenue, USD Billion, 2018 – 2030)
- Diagnostic Imaging Centers
List of Key Players in U.K. Imaging Services Market
- Alliance Medical
- InHealth Group
- Neuromed Diagnostic Imaging Center
- Medica Group
- TIC Health
- The radiology Clinic
- Affidea Group
- Vista Health
- Medical Imaging Partnership
- Rutherford Diagnostics
Grand View Research is an India & U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.
Grand View Research
Office No. 705, A Wing, 7th Floor,
Amar Business Zone,
Veerbhadra Nagar, Baner,
Pune, MH, 411045 India
Phone: +91-895-638-0888 (Sales)
Phone: +91-895-638-0891 (HR)